F. Nozawa Et Al. , "The combination of tumor necrosis factor-related apoptosis-inducing ligand (TRAIL/Apo2L) and Genistein is effective in inhibiting pancreatic cancer growth.," Pancreas , vol.29, pp.45-52, 2004
Nozawa, F. Et Al. 2004. The combination of tumor necrosis factor-related apoptosis-inducing ligand (TRAIL/Apo2L) and Genistein is effective in inhibiting pancreatic cancer growth.. Pancreas , vol.29 , 45-52.
Nozawa, F., Itami, A., Saruc, M., Kim, M., Standop, J., Picha, K., ... Cowan, K.(2004). The combination of tumor necrosis factor-related apoptosis-inducing ligand (TRAIL/Apo2L) and Genistein is effective in inhibiting pancreatic cancer growth.. Pancreas , vol.29, 45-52.
Nozawa, F Et Al. "The combination of tumor necrosis factor-related apoptosis-inducing ligand (TRAIL/Apo2L) and Genistein is effective in inhibiting pancreatic cancer growth.," Pancreas , vol.29, 45-52, 2004
Nozawa, F Et Al. "The combination of tumor necrosis factor-related apoptosis-inducing ligand (TRAIL/Apo2L) and Genistein is effective in inhibiting pancreatic cancer growth.." Pancreas , vol.29, pp.45-52, 2004
Nozawa, F. Et Al. (2004) . "The combination of tumor necrosis factor-related apoptosis-inducing ligand (TRAIL/Apo2L) and Genistein is effective in inhibiting pancreatic cancer growth.." Pancreas , vol.29, pp.45-52.
@article{article, author={F Nozawa Et Al. }, title={The combination of tumor necrosis factor-related apoptosis-inducing ligand (TRAIL/Apo2L) and Genistein is effective in inhibiting pancreatic cancer growth.}, journal={Pancreas}, year=2004, pages={45-52} }